Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2007
The concept of using antibacterial agents to prevent infectious endocarditis (IE) was proposed more than 60 years ago1and was first endorsed by the American Heart Association (AHA) in its recommendations for IE prophylaxis published in 1955.2Since that time, IE prophylaxis has become a widely accepted preventive measure, broadly endorsed by a number of international professional societies, representing cardiologists, gastroenterologists, infectious diseases specialists, dentists, and pediatricians.2
Seto TB. The Case for Infectious Endocarditis ProphylaxisTime to Move Forward. Arch Intern Med. 2007;167(4):327–330. doi:10.1001/archinte.167.4.327
Customize your JAMA Network experience by selecting one or more topics from the list below.